HLB Life Science Co.,Ltd.(KR:067630)
₩2,430.00-85.00 (-3.38%)
KR:067630
HLB Life Science Co.,Ltd. financials statements
₩2,430.00
At close:-85.00 (-3.38%)
Want to see KR:067630 full AI Analyst Report?
HLB Life Science Co.,Ltd. (067630) Income Statement
HLB Life Science Co.,Ltd. Income Statement
Last quarter (Q4 2025), HLB Life Science Co.,Ltd.'s total revenue was ₩10.95B, a decrease of 61.83% from the same quarter last year. In Q4, HLB Life Science Co.,Ltd.'s net income was ₩20.08B. See HLB Life Science Co.,Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₩ 45.75B | ₩ 102.24B | ₩ 97.99B | ₩ 99.59B | ₩ 53.49B | |
| ₩ -494.41M | ₩ -2.19B | ₩ -748.57M | ₩ -3.05B | ₩ -5.54B | |
| ₩ 20.53B | ₩ 22.63B | ₩ 23.78B | ₩ 17.11B | ₩ 12.94B | |
| Depreciation and Amortization | ₩ 5.25B | ₩ 5.90B | ₩ 7.70B | ₩ 5.22B | ₩ 2.48B |
| ₩ -83.58B | ₩ 25.87B | ₩ 22.84B | ₩ -45.75B | ₩ -49.88B | |
| ₩ -21.02B | ₩ -24.82B | ₩ -24.53B | ₩ -20.16B | ₩ -18.48B | |
| ₩ -79.54B | ₩ 27.97B | ₩ 18.03B | ₩ -40.68B | ₩ -35.14B | |
| ₩ -100.57B | ₩ 3.15B | ₩ -6.50B | ₩ -60.84B | ₩ -53.62B | |
| ₩ -99.79B | ₩ 6.14B | ₩ -5.98B | ₩ -54.36B | ₩ -49.29B | |
| Per Share Metrics | |||||
| Basic EPS | ₩ -818.56 | ₩ 56.64 | ₩ -54.79 | ₩ -533.76 | ₩ -467.10 |
| Diluted EPS | ₩ -818.56 | ₩ 56.64 | ₩ -54.79 | ₩ -533.76 | ₩ -467.10 |
| Weighted Average Shares Outstanding | 121.92M | 108.37M | 106.84M | 106.84M | 106.84M |
| Weighted Average Shares Outstanding (Diluted) | 121.92M | 108.37M | 106.84M | 106.84M | 106.84M |
Currency in KRW

